FLUDARA
Land: Israel
Sprog: engelsk
Kilde: Ministry of Health
Nogle dokumenter til dette produkt er ikke tilgængelige i øjeblikket, du kan sende en anmodning til vores kundeservice, og vi vil underrette dig, så snart vi er i stand til at få dem.
Send anmodning.
Send anmodning.
Aktiv bestanddel:
FLUDARABINE PHOSPHATE 50 MG/VIAL
Tilgængelig fra:
SANOFI - AVENTIS ISRAEL LTD
ATC-kode:
L01BB05
Lægemiddelform:
POWDER FOR SOLUTION FOR INJ/INF
Indgivelsesvej:
I.V
Fremstillet af:
GENZYME EUROPE B.V., NETHERLANDS
Terapeutisk gruppe:
FLUDARABINE
Terapeutiske indikationer:
Palliative treatment of patients with CLL refractory to other therapy. Treatment of less malignant Non-Hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. Fludara is indicated for the initial treatment of patients with B- cell chronic lymphocytic leukaemia (CLL) or after first line therapy, in patients with sufficient bone marrow reserves.
Autorisation dato:
2009-02-01
